Issue 5/2025
Content (17 Articles)
Systematic Literature Review and Network Meta-Analysis of Clinical Efficacy and Safety of Topical Treatments for Patients with Atopic Dermatitis
- Open Access
- Atopic Dermatitis
- Review
Hiroyuki Murota, Takeshi Nakahara, Xinyu Wang, Miyuki Matsukawa, Hiroe Takeda, Tomohiro Kondo, Kentaro Yamato
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel
- Open Access
- Atopic Dermatitis
- Review
Alessandra Narcisi, Vito Di Lernia, Maria Esposito, Vittorio Forte, Silvia Mariel Ferrucci, Lorenzo Gerratana, Pietro Morrone, Saverio Muscoli, Maddalena Napolitano, Michela Ortoncelli, Marina Talamonti
CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study
- Open Access
- Adalimumab
- Original Research
David M. Pariser, Mark G. Lebwohl, Janusz Jaworski, Jakub Trefler, Stefan Daniluk, Anna Dudek, Wojciech Baran, Witold Owczarek, Pawel Brzewski, Mariusz Sikora, Marek Krogulec, SungHyun Kim, JeeHye Suh, EunJin Choi, JungBin Cha, HyunJin Lee, SungJeong Lee, John Y. Koo
Hidradenitis Suppurativa Symptom Daily Diary (HSSDD) and Questionnaire (HSSQ): Psychometric Validation and Interpretation Threshold Derivation Using Phase 3 Study Data
- Open Access
- Acne Inversa
- Original Research
John R. Ingram, Jérémy Lambert, Valerie Ciaravino, Robert Rolleri, Ingrid Pansar, Luke Peterson, Christopher G. Pelligra, Linnea Thorlacius
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector
- Open Access
- Plaque Psoriasis
- Original Research
Michael Sebastian, Jerry Bagel, Bengt Hoepken, Bertram Knapp, Ceyhun Bicer, Merran MacPherson, Richard G. Langley
Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens
- Open Access
- Wart
- Original Research
Stacy R. Smith, Robert E. Esch, H. S. Nielsen, Sandra Marchese Johnson
Generalized Pustular Psoriasis Brazilian Experts Survey: Challenges in Disease Management
- Open Access
- Generalized Pustular Psoriasis
- Original Research
Ricardo Romiti, André V. E. de Carvalho, Cinara P. C. C. Soares, Gleison Duarte
Impacts of Topical Treatments and Phototherapy on Stratum Corneum Hydration, Sebum and Elasticity in Vitiligo Skin
- Open Access
- Vitiligo
- Original Research
Yaqing Wen, Issa Ali Issa, Li Lei, Chuhan Fu, Shu Zhou, Keyi Zhang, Jiangfeng Huang, Jing Chen, Qinghai Zeng, Ling Jiang
Risk of Superficial Fungal Infections in WHIM Syndrome
- Open Access
- Pityriasis Versicolor
- Original Research
Jennifer Strong, Rutha Adhanom, Caleb S. Kim, Yoshine Saito, Jasmine C. Meltzer, Patrick Hallaert, Sophia Martinez, Abigail Salancy, Heidi H. Kong, Edward W. Cowen, Leslie Castelo-Soccio, Philip M. Murphy, David H. McDermott, Isaac Brownell
Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream
- Open Access
- Original Research
Timo Buhl, Andrea Bauer, Benjamin D. Ehst, Jacob P. Thyssen, Julie Hahn-Pedersen, Berith Fredsted Hagen, Eydna D. Apol, Tove Agner
Demographics and Clinical Characteristics among Patients with Distinct Psychosocial Burden Profiles Related to Vitiligo: Results of a Latent Class Analysis
- Open Access
- Vitiligo
- Original Research
Kent A. Hanson, Khaled Ezzedine, Jenny Austin, Peter Anderson, Simran Marwaha, Samantha K. Kurosky, Roni Adiri, James Piercy, Ernest H. Law
In Vitro and In Vivo Assessment of an Innovative Peeling System with Azelaic and Tranexamic Acids for Targeted Hyperpigmentation Reduction
- Open Access
- Hyperpigmentation
- Original Research
Russell Wong, Mariangela G. de O. Sichmann, James Sun, Alexis R. Kim, Robert J. Bianchini, Kevin D. Hermanson, Louis Chabert
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies
- Open Access
- Ruxolitinib
- Brief Report
Julien Seneschal, Albert Wolkerstorfer, Seemal R. Desai, Pearl Grimes, Khaled Ezzedine, Amit G. Pandya, Deanna Kornacki, Shaoceng Wei, Thierry Passeron, David Rosmarin
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
- Open Access
- Guselkumab
- Brief Report
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, Matteo Megna, Annunziata Raimondo, Giacomo Caldarola, Nicoletta Bernardini, Anna Balato, Anna Campanati, Maria Esposito, Claudio Bonifati, Viviana Lora, Luca Potestio, Serena Lembo, Francesco Loconsole, Eleonora De Luca, Nevena Skroza, Dario Buononato, Tommaso Bianchelli, Maria Concetta Fargnoli, Nello Tommasino, Felice Primavera, Clara De Simone, Luca Bianchi, Marco Galluzzo
Long-Term Efficacy and Potential Predictors of Tralokinumab Dose Optimization in Elderly Patients: A Multicentre Study
- Open Access
- Atopic Dermatitis
- Brief Report
Francisco Javier Melgosa Ramos, Sergio Santos Alarcón, Jose María Sánchez Motilla, Pedro Mercader
Tumoral Melanosis: A Case Series of a Rare Clinical Entity
- Open Access
- Melanoma
- Case Series
Cesare Ariasi, Grazia Linda Artelli, Cristina Zane, Martina Perantoni, Simone Soglia, Giuseppe La Rosa, Vincenzo Maione, Marina Venturini, Claudia Zambelli, Gaetano Licata, Mariateresa Rossi, Mariachiara Arisi
Correction: Tumoral Melanosis: A Case Series of a Rare Clinical Entity
- Open Access
- Melanoma
- Correction
Cesare Ariasi, Grazia Linda Artelli, Cristina Zane, Martina Perantoni, Simone Soglia, Giuseppe La Rosa, Vincenzo Maione, Marina Venturini, Claudia Zambelli, Gaetano Licata, Mariateresa Rossi, Mariachiara Arisi
